** Shares of Trajan Group Holdings rise as much as 5% to A$1.260, posting their biggest intraday pct gain since Sept. 10
** Life sciences co says Q1 total net revenue up in high single-digit over pcp
** Maintains FY25 net revenue forecast of A$160.0 mln ($105.31 mln) to A$165.0 mln, and group nEBITDA of A$17.0 mln to A$19.0 mln
** Co had reported net revenue of A$155 mln and group normalised EBITDA of A$17.1 mln for fiscal 2024
** Stock hits highest level since Oct. 7
** TRJ up 2% YTD, as of 0225 GMT
($1 = 1.5193 Australian dollars)
(Reporting by Adwitiya Srivastava in Bengaluru)
((Adwitiya.Srivastava@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。